Pillow

Children’s Medical Ventures (CMV), a Philips Healthcare business unit, is voluntarily recalling all Gel-E Donut gel pillow and Squishon 2 gel cushion products, over potential mould contamination.

The recalled products were manufactured and distributed between July 2012 and August 2014.

The move follows a previous recall for these products announced in May, due to mould contamination of some products, which occurred during the manufacturing process.

At the time of initial recall, the company implemented a process intended to reduce the presence of viable mould on the products prior to shipment.

Gel-E Donut gel pillow and Squishon 2 gel cushions were developed to provide support for an infant’s head or body in a hospital environment.

The products can also be used in Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU) and neonatal care centres.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"The recalled products were manufactured and distributed between July 2012 and August 2014."

CMV is asking customers to stop using and dispose of all Gel-E Donut gel pillow and Squishon 2 gel cushion products in their facility, even if mould is not visible.

According to the company, the affected products were shipped to countries, including the US, Australia, Austria, Belgium, Canada, France, Germany, Iceland, Ireland and Italy.

Additionally, the products are supplied in Japan, Kuwait, Netherlands, New Zealand, Norway, Portugal, Reunion, Romania, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Thailand and the UK.

The company said that adverse reactions or quality problems experienced with the use of this product should be reported to FDA’s MedWatch Adverse Event Reporting programme.


Image: The Children’s Medical Ventures Gel-E Donut. Photo: courtesy of PRNewswire / Philips Healthcare.